Target (CBDY) Shares Outstanding (Weighted Average) (2013 - 2023)
Target (CBDY) reported Shares Outstanding (Weighted Average) of $456.4 million for Q1 2023, down 26.03% year-over-year from $617.0 million in Q1 2022, and up 1048.35% quarter-over-quarter from $39.7 million in Q4 2022.
Target (CBDY) Shares Outstanding (Weighted Average) (2013 - 2023) Analysis & Trends
Target (CBDY) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $456.4 million in Q1 2023.
- Shares Outstanding (Weighted Average) for Q1 2023 came in at $456.4 million, down 26.03% year-over-year; the trailing twelve-month figure through Mar 2023 was $456.4 million (down 26.03% YoY), and the FY2022 annual result was $39.7 million, down 85.69% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $456.4 million in Q1 2023 per CBDY's latest filing, from $39.7 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $617.0 million in Q1 2022 and troughed at $7.2 million in Q2 2019.
- A 4-year average of $323.5 million and a median of $421.9 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 24.9% in 2022 and fell as far as 85.69% in 2022.
- A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $7.2 million in 2019, then jumped by 3752.46% to $277.8 million in 2021, then tumbled by 85.69% to $39.7 million in 2022, then jumped by 1048.35% to $456.4 million in 2023.
- Business Quant data shows CBDY's Shares Outstanding (Weighted Average) at $456.4 million in Q1 2023, $39.7 million in Q4 2022, and $473.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 456.41 Mn |
| Dec 31, 2022 | 39.75 Mn |
| Sep 30, 2022 | 473.10 Mn |
| Jun 30, 2022 | 483.96 Mn |
| Mar 31, 2022 | 617.03 Mn |
| Dec 31, 2021 | 277.81 Mn |
| Sep 30, 2021 | 467.39 Mn |
| Jun 30, 2021 | 387.47 Mn |
| Jun 30, 2019 | 7.21 Mn |
| Mar 31, 2019 | 25.00 Mn |
| Sep 30, 2018 | 25.00 Mn |
| Jun 30, 2018 | 26.28 Mn |
| Mar 31, 2018 | 20.27 Mn |
| Dec 31, 2017 | 2.41 Mn |
| Sep 30, 2017 | 623,314.00 |
| Jun 30, 2017 | 158,333.00 |
| Mar 31, 2017 | 48,697.00 |
| Dec 31, 2016 | 27,316.00 |
| Sep 30, 2016 | 24,664.00 |
| Jun 30, 2016 | 21.87 Mn |